New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments
SHENZHEN, China , Sept. 2 /PRNewswire-Asia/ — In a new peer-reviewed article published by the Journal of Translational Medicine, scientists from Beike Biotechnology ( http://www.beikebiotech.com/ ), China …
[Read the full article here]Related News:
Beike Biotech Launches New International Stem Cell Venture
Adult Stem Cell Study Demonstrates Improved Quality Of Life For Patients Suffering From Spinal Cord Injury
China Breaks Ground on Largest Comprehensive Stem Cell Storage and Processing Facility